Piceamycin and its N-acetylcysteine adduct is produced by Streptomyces sp. GB 4-2. 2009

Dirk Schulz, and Jonny Nachtigall, and Julia Riedlinger, and Kathrin Schneider, and Karl Poralla, and Johannes F Imhoff, and Winfried Beil, and Graeme Nicholson, and Hans-Peter Fiedler, and Roderich D Süssmuth
Mikrobiologisches Institut, Universität Tübingen, Tübingen, Germany.

Piceamycin, a new macrolactam polyketide antibiotic, was detected by HPLC-diode array screening in extracts of Streptomyces sp. GB 4-2, which was isolated from the mycorrhizosphere of Norway spruce. The structure of piceamycin was determined by mass spectrometry and NMR experiments. It showed inhibitory activity against Gram-positive bacteria, selected human tumor cell lines and protein tyrosine phosphatase 1B.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000111 Acetylcysteine The N-acetyl derivative of CYSTEINE. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates. Mercapturic Acid,Acemuc,Acetabs,Acetylcystein AL,Acetylcystein Atid,Acetylcystein Heumann,Acetylcystein Trom,Acetylcysteine Hydrochloride,Acetylcysteine Sodium,Acetylcysteine Zinc,Acetylcysteine, (D)-Isomer,Acetylcysteine, (DL)-Isomer,Acetylcysteine, Monoammonium Salt,Acetylcysteine, Monosodium Salt,Acetylin,Acetyst,Acétylcystéine GNR,Airbron,Alveolex,Azubronchin,Bisolvon NAC,Bromuc,Broncho-Fips,Broncholysin,Broncoclar,Codotussyl,Cystamucil,Dampo Mucopect,Eurespiran,Exomuc,Fabrol,Fluimucil,Fluprowit,Frekatuss,Genac,Hoestil,Ilube,Jenacystein,Jenapharm,Lantamed,Larylin NAC,Lindocetyl,M-Pectil,Muciteran,Muco Sanigen,Mucomyst,Mucosil,Mucosol,Mucosolvin,N-Acetyl-L-cysteine,N-Acetylcysteine,NAC AL,NAC Zambon,Optipect Hustengetränk,Siccoral,Siran,Solmucol,acebraus,durabronchal,mentopin Acetylcystein,Acetylcystein, mentopin,Acid, Mercapturic,Broncho Fips,BronchoFips,Hustengetränk, Optipect,Hydrochloride, Acetylcysteine,M Pectil,MPectil,Monoammonium Salt Acetylcysteine,Monosodium Salt Acetylcysteine,Mucopect, Dampo,N Acetyl L cysteine,N Acetylcysteine,NAC, Bisolvon,Sanigen, Muco,Sodium, Acetylcysteine,Zambon, NAC,Zinc, Acetylcysteine
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Dirk Schulz, and Jonny Nachtigall, and Julia Riedlinger, and Kathrin Schneider, and Karl Poralla, and Johannes F Imhoff, and Winfried Beil, and Graeme Nicholson, and Hans-Peter Fiedler, and Roderich D Süssmuth
September 2014, Chemico-biological interactions,
Dirk Schulz, and Jonny Nachtigall, and Julia Riedlinger, and Kathrin Schneider, and Karl Poralla, and Johannes F Imhoff, and Winfried Beil, and Graeme Nicholson, and Hans-Peter Fiedler, and Roderich D Süssmuth
May 1969, Applied microbiology,
Dirk Schulz, and Jonny Nachtigall, and Julia Riedlinger, and Kathrin Schneider, and Karl Poralla, and Johannes F Imhoff, and Winfried Beil, and Graeme Nicholson, and Hans-Peter Fiedler, and Roderich D Süssmuth
August 1976, The Journal of antibiotics,
Dirk Schulz, and Jonny Nachtigall, and Julia Riedlinger, and Kathrin Schneider, and Karl Poralla, and Johannes F Imhoff, and Winfried Beil, and Graeme Nicholson, and Hans-Peter Fiedler, and Roderich D Süssmuth
January 2003, Applied and environmental microbiology,
Dirk Schulz, and Jonny Nachtigall, and Julia Riedlinger, and Kathrin Schneider, and Karl Poralla, and Johannes F Imhoff, and Winfried Beil, and Graeme Nicholson, and Hans-Peter Fiedler, and Roderich D Süssmuth
February 1953, The Journal of antibiotics,
Dirk Schulz, and Jonny Nachtigall, and Julia Riedlinger, and Kathrin Schneider, and Karl Poralla, and Johannes F Imhoff, and Winfried Beil, and Graeme Nicholson, and Hans-Peter Fiedler, and Roderich D Süssmuth
October 1994, The Journal of antibiotics,
Dirk Schulz, and Jonny Nachtigall, and Julia Riedlinger, and Kathrin Schneider, and Karl Poralla, and Johannes F Imhoff, and Winfried Beil, and Graeme Nicholson, and Hans-Peter Fiedler, and Roderich D Süssmuth
October 2003, Bioorganic & medicinal chemistry,
Dirk Schulz, and Jonny Nachtigall, and Julia Riedlinger, and Kathrin Schneider, and Karl Poralla, and Johannes F Imhoff, and Winfried Beil, and Graeme Nicholson, and Hans-Peter Fiedler, and Roderich D Süssmuth
August 1982, The Journal of antibiotics,
Dirk Schulz, and Jonny Nachtigall, and Julia Riedlinger, and Kathrin Schneider, and Karl Poralla, and Johannes F Imhoff, and Winfried Beil, and Graeme Nicholson, and Hans-Peter Fiedler, and Roderich D Süssmuth
January 2018, 3 Biotech,
Dirk Schulz, and Jonny Nachtigall, and Julia Riedlinger, and Kathrin Schneider, and Karl Poralla, and Johannes F Imhoff, and Winfried Beil, and Graeme Nicholson, and Hans-Peter Fiedler, and Roderich D Süssmuth
October 1985, The Journal of antibiotics,
Copied contents to your clipboard!